Capital World Investors
ARNA

Capital World Investors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Capital World Investors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-500,000
Closed -$26.4M – 500
2013
Q3 		$26.4M Hold
500,000
– – 0.01% 389
2013
Q2 		$38.5M Buy
+500,000
New +$40.8M 0.01% 351

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Capital World Investors's ARNA Position: Q4 2013 in Review

Capital World Investors sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2013, closing a stake of 500,000 shares — an estimated $26.4M sold.

Capital World Investors first reported a position in ARNA in Q2 2013 and held it in 2 quarters. The position peaked at $38.5M in Q2 2013. 134 funds tracked by Wall St. Rank hold ARNA as of Q4 2013.

  • Capital World Investors reported no remaining Arena Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • Capital World Investors sold 500,000 Arena Pharmaceuticals Inc shares in Q4 2013, an estimated $26.4M.
  • Capital World Investors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 2 quarters.
  • Capital World Investors's Arena Pharmaceuticals Inc position peaked at $38.5M in Q2 2013.
  • 134 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2013.

Based on Capital World Investors's 13F filing for Q4 2013, filed 14 Feb 2014.